Microvesicles - potential biomarkers for the interrelations atherosclerosis/type 2 diabetes mellitus.

Microvesicles, also called microparticles or exosomes, are ultrastructural cellular components that have been widely researched in the past as well as present in order to establish their morphology, origin and role in physiological and pathological processes. Advanced techniques show that these microparticles have their clinical implications in the prevention and prediction in pathology and have potential in the discovery of novel therapeutic approaches to metabolic diseases such as diabetes, cardiovascular, autoimmune diseases and cancer.

[1]  C. Théry.  Exosomes: secreted vesicles and intercellular communications , 2011, F1000 biology reports.

[2]  R. Virmani,et al.  Morphological characteristics of coronary atherosclerosis in diabetes mellitus. , 2006, The Canadian journal of cardiology.

[3]  R. Imrich,et al.  Microparticles: a component of various diseases. , 2012, Polskie Archiwum Medycyny Wewnetrznej.

[4]  F. Gaita,et al.  Atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: a meta-regression of randomized clinical trials. , 2013, Atherosclerosis.

[5]  D. Mozaffarian,et al.  The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. , 2008, Clinical chemistry.

[6]  M. Matsuhisa,et al.  Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease. , 2000, Diabetes care.

[7]  R. Virmani,et al.  Morphologic Findings of Coronary Atherosclerotic Plaques in Diabetics: A Postmortem Study , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[8]  Jinsun Park,et al.  The relationship between volumetric plaque components and classical cardiovascular risk factors and the metabolic syndrome a 3-vessel coronary artery virtual histology-intravascular ultrasound analysis. , 2011, JACC. Cardiovascular interventions.

[9]  L. Holmgren,et al.  Horizontal Transfer of DNA by the Uptake of Apoptotic Bodies , 1999, Vox sanguinis.

[10]  C. White,et al.  Unstable angina. A comparison of angioscopic findings between diabetic and nondiabetic patients. , 1995, Circulation.

[11]  M. Neurath,et al.  RAGE Mediates a Novel Proinflammatory Axis A Central Cell Surface Receptor for S100/Calgranulin Polypeptides , 1999, Cell.

[12]  ZiadMallat,et al.  Elevated Levels of Shed Membrane Microparticles With Procoagulant Potential in the Peripheral Circulating Blood of Patients With Acute Coronary Syndromes , 2000 .

[13]  Veronika Kralj-Iglic,et al.  Isolated microvesicles from peripheral blood and body fluids as observed by scanning electron microscope. , 2010, Blood cells, molecules & diseases.

[14]  F. Cipollone,et al.  Balance Between PGD Synthase and PGE Synthase Is a Major Determinant of Atherosclerotic Plaque Instability in Humans , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[15]  Q. Qiao,et al.  Cardiovascular Diseases and Diabetes , 2012 .

[16]  M. Bajaj,et al.  Adiponectin and vulnerable atherosclerotic plaques. , 2011, Journal of the American College of Cardiology.

[17]  Kathryn A. O’Donnell,et al.  Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model , 2009, Cell.

[18]  G. Müller,et al.  Microvesicles/exosomes as potential novel biomarkers of metabolic diseases , 2012, Diabetes, metabolic syndrome and obesity : targets and therapy.

[19]  Philipp E. Scherer,et al.  A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.

[20]  R. Donato,et al.  S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. , 2001, The international journal of biochemistry & cell biology.

[21]  R. Flaumenhaft,et al.  Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. , 2009, Blood.

[22]  J. Freyssinet,et al.  Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus , 2004, Thrombosis and Haemostasis.

[23]  I. Ernberg,et al.  Horizontal transfer of DNA by the uptake of apoptotic bodies. , 1999, Blood.

[24]  J. Freyssinet,et al.  Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. , 2000, Circulation.

[25]  K. Walder,et al.  The small leucine-rich proteoglycan, biglycan, is highly expressed in adipose tissue of Psammomys obesus and is associated with obesity and type 2 diabetes , 2012, Biologics : targets & therapy.

[26]  C. Ludlam,et al.  Plasma microparticles and vascular disorders , 2007, British journal of haematology.

[27]  György Nagy,et al.  Cellular and Molecular Life Sciences REVIEW Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles , 2022 .

[28]  Raimund Erbel,et al.  Serial intravascular ultrasound assessment of changes in coronary atherosclerotic plaque dimensions and composition: an update. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[29]  O. Morel,et al.  Elevated levels of procoagulant microparticles in a patient with myocardial infarction, antiphospholipid antibodies and multifocal cardiac thrombosis , 2005, Thrombosis journal.

[30]  J. Lovegrove,et al.  Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress. , 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[31]  H. Lodish,et al.  MicroRNAs Induced During Adipogenesis that Accelerate Fat Cell Development Are Downregulated in Obesity , 2009, Diabetes.

[32]  D. Lewis,et al.  Flow cytometric analysis of circulating microparticles in plasma , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[33]  C. Georgescu,et al.  Study of cerebral vascular structures in hypertensive intracerebral haemorrhage. , 2005, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[34]  Lars Holmgren,et al.  Horizontal transfer of oncogenes by uptake of apoptotic bodies , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Rich,et al.  Increased prevalence of significant coronary artery calcification in patients with diabetes. , 2001, Diabetes care.

[36]  G. Getz,et al.  Site Specificity of Atherosclerosis: Site-Selective Responses to Atherosclerotic Modulators , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[37]  J. Beckman,et al.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I , 2013, European heart journal.

[38]  A. Barnett,et al.  DPP‐4 inhibitors and their potential role in the management of type 2 diabetes , 2006, International journal of clinical practice.

[39]  A. Piccin,et al.  Circulating microparticles: pathophysiology and clinical implications. , 2007, Blood reviews.